Emerging strategies and therapies for treatment of Paget’s disease of bone

References

• RoodmanGDWindleJJPaget disease of boneJ Clin Invest2005115220020815690073
   PubMed Web of Science ®Google Scholar
• NaotDBavaUMatthewsBDifferential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget’s disease of boneJ Bone Miner Res200722229830917129176
   PubMed Web of Science ®Google Scholar
• VellengaCJPauwelsEKBijvoetOLFrijlinkWBScintigraphic aspects of the recurrence of treated Paget’s disease of boneJ Nucl Med19812265105177229723
   PubMed Web of Science ®Google Scholar
• HamadoucheMMathieuMTopouchianVde PinieuxGCourpiedJPTransfer of Paget’s disease from one part of the skeleton to another as a result of autogenous bone-grafting: A case reportJ Bone Joint Surg Am.200284-A112056206112429770
   PubMed Web of Science ®Google Scholar
• MeunierPJCoindreJMEdouardCMArlotMEBone histomorphometry in Paget’s disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissueArthritis Rheum19802310109511037426075
   PubMed Web of Science ®Google Scholar
• EekhoffMEvan der KliftMKroonHMPaget’s disease of bone in The Netherlands: A population-based radiological and biochemical survey – the Rotterdam StudyJ Bone Miner Res200419456657015005843
   PubMed Web of Science ®Google Scholar
• RogersJJeffreyDRWattIPaget’s disease in archeological populationJ Bone Miner Res20021761127113412054169
   PubMed Web of Science ®Google Scholar
• WaldronHARecalculation of secular trends in Paget’s diseaseJ Bone Miner Res.200419352315049284
   PubMed Web of Science ®Google Scholar
• Van StaaTPSelbyPLeufkensHGLylesKSprafkaJMCooperCIncidence and natural history of Paget’s disease of bone in England and WalesJ Bone Miner Res200217346547111878305
   PubMed Web of Science ®Google Scholar
• SelbyPLDavieMWRalstonSHStoneMDGuidelines on the management of Paget’s disease of boneBone200231336637312231408
   PubMed Web of Science ®Google Scholar
• RousiereMMichouLCornelisFOrcelPPaget’s disease of boneBest Pract Res Clin Rheumatol20031761019104115123049
   PubMed Web of Science ®Google Scholar
• SetonMMosesAMBodeRKSchwartzCPaget’s disease of bone: The skeletal distribution, complications and quality of life as perceived by patientsBone201148228128520858558
   PubMed Web of Science ®Google Scholar
• RebelAMalkaniKBasleM[Nuclear anomalies in osteoclasts in Paget’s bone disease]Nouv Presse Med197432012991301 French.4843079
   PubMedGoogle Scholar
• RebelAMalkaniKBasleMBregeonCOsteoclast ultrastructure in Paget’s diseaseCalcif Tissue Res19762187199177153
   PubMedGoogle Scholar
• GordonMTAndersonDCSharpePTCanine distemper virus localised in bone cells of patients with Paget’s diseaseBone19911231952011910961
   PubMed Web of Science ®Google Scholar
• GordonMTMeeAPAndersonDCSharpePTCanine distemper virus transcripts sequenced from pagetic boneBone Miner19921921591741345324
   PubMedGoogle Scholar
• MeeAPDixonJAHoylandJADaviesMSelbyPLMawerEBDetection of canine distemper virus in 100% of Paget’s disease samples by in situ-reverse transcriptase-polymerase chain reactionBone19982321711759701477
   PubMed Web of Science ®Google Scholar
• HoylandJADixonJABerryJLDaviesMSelbyPLMeeAPA comparison of in situ hybridisation, reverse transcriptase-polymerase chain reaction (RT-PCR) and in situ-RT-PCR for the detection of canine distemper virus RNA in Paget’s diseaseJ Virol Methods2003109225325912711070
   PubMed Web of Science ®Google Scholar
• ReddySVSingerFRRoodmanGDBone marrow mononuclear cells from patients with Paget’s disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequenceJ Clin Endocrinol Metab1995807210821117608263
   PubMed Web of Science ®Google Scholar
• FriedrichsWEReddySVBruderJMSequence analysis of measles virus nucleocapsid transcripts in patients with Paget’s diseaseJ Bone Miner Res200217114515111771661
   PubMed Web of Science ®Google Scholar
• CodyJDSingerFRRoodmanGDGenetic linkage of Paget disease of the bone to chromosome 18qAm J Hum Genet1997615111711229345096
   PubMed Web of Science ®Google Scholar
• RalstonSHAfzalMAHelfrichMHMulticenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget’s disease of boneJ Bone Miner Res200722456957717227218
   PubMed Web of Science ®Google Scholar
• MerlottiDGennariLGalliBCharacteristics and familial aggregation of Paget’s disease of bone in ItalyJ Bone Miner Res20052081356136416007333
   PubMed Web of Science ®Google Scholar
• SetonMChoiHKHansenMFSebaldtRJCooperCAnalysis of environmental factors in familial versus sporadic Paget’s disease of bone – the New England Registry for Paget’s Disease of BoneJ Bone Miner Res20031881519152412929942
   PubMed Web of Science ®Google Scholar
• Lopez-AbenteGMorales-PigaAElena-IbanezARey-ReyJSCorres-GonzalezJCattle, pets, and Paget’s disease of boneEpidemiology1997832472519115018
   PubMed Web of Science ®Google Scholar
• CundyTIs the prevalence of Paget’s disease of bone decreasing?J Bone Miner Res.200621Suppl 2P9P1317229016
   PubMed Web of Science ®Google Scholar
• CooperCHarveyNCDennisonEMvan StaaTPUpdate on the epidemiology of Paget’s disease of boneJ Bone Miner Res.200621Suppl 2P3P817229005
   PubMed Web of Science ®Google Scholar
• RalstonSHLangstonALReidIRPathogenesis and management of Paget’s disease of boneLancet2008372963315516318620951
   PubMed Web of Science ®Google Scholar
• GennariLDi StefanoMMerlottiDPrevalence of Paget’s disease of bone in ItalyJ Bone Miner Res200520101845185016160742
   PubMed Web of Science ®Google Scholar
• RendinaDGennariLDe FilippoGEvidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, southern ItalyJ Bone Miner Res200621121828183517002563
   PubMed Web of Science ®Google Scholar
• HaddawayMJDavieMWMcCallIWHowdleSEffect of age and gender on the number and distribution of sites in Paget’s disease of boneBr J Radiol20078095553253617646188
   PubMed Web of Science ®Google Scholar
• JosseRGHanleyDAKendlerDSte-MarieLGAdachiJDBrownJDiagnosis and treatment of Paget’s disease of boneClin Invest Med2007305E210E22317892763
   PubMed Web of Science ®Google Scholar
• MeunierPJSalsonCDelmasPD[Skeletal distribution and biological markers of Paget’s disease]Rev Prat1989391311251128 French.2786643
   PubMedGoogle Scholar
• KanisJABiochemical and endocrine aspects of Paget’s diseaseKanisJAPathophysiology and Treatment of Paget’s Disease of Bone2nd edLondonMartin Dunitz Ltd1998
   Google Scholar
• LylesKLSirisESSingerFRMeunierPJA clinical approach to diagnosis and management of Paget’s disease of boneJ Bone Miner Res20011681379138711499860
   PubMed Web of Science ®Google Scholar
• ReidIRDavidsonJSWattieDComparative responses of bone turnover markers to bisphosphonate therapy in Paget’s disease of boneBone200435122423015207761
   PubMed Web of Science ®Google Scholar
• AlvarezLGuanabensNPerisPUsefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget’s diseaseBone200129544745211704497
   PubMed Web of Science ®Google Scholar
• AlexandersenPPerisPGuanabensNNon-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget’s disease of boneJ Bone Miner Res200520458859515765177
   PubMed Web of Science ®Google Scholar
• ShankarSHoskingDJBiochemical assessment of Paget’s disease of boneJ Bone Miner Res.200621Suppl 2P22P2717229003
   PubMed Web of Science ®Google Scholar
• MagnussonPDavieMWSharpCACirculating and tissue-derived isoforms of bone alkaline phosphatase in Paget’s disease of boneScand J Clin Lab Invest201070212813520175736
   PubMed Web of Science ®Google Scholar
• DelmasPDDemiauxBMalavalLChapuyMCMeunierPJSerum bone GLA-protein is not a sensitive marker of bone turnover in Paget’s disease of boneCalcif Tissue Int198638160613079654
   PubMed Web of Science ®Google Scholar
• ReidIRDavidsonJSWattieDComparative responses of bone turnover markers to bisphosphonate therapy in Paget’s disease of boneBone200435122423015207761
   PubMed Web of Science ®Google Scholar
• RenierJCFanelloSRodriguezNAudranMCurrent prevalence of Paget’s disease of bone in a region of France (Anjou)Rev Rhum Engl Ed19956295715758574629
   PubMedGoogle Scholar
• MeunierPJSalsonCMathieuLSkeletal distribution and biochemical parameters of Paget’s diseaseClin Orthop198721737443103964
   PubMed Web of Science ®Google Scholar
• DaroszewskaARalstonSHMechanisms of disease: Genetics of Paget’s disease of bone and related disordersNat Clin Pract Rheumatol20062527027716932700
   PubMedGoogle Scholar
• Morales-PigaAARey-ReyJSCorres-GonzalezJGarcia-SagredoJMLopez-AbenteGFrequency and characteristics of familial aggregation of Paget’s disease of boneJ Bone Miner Res19951046636707610939
   PubMed Web of Science ®Google Scholar
• SirisESOttmanRFlasterEKelseyJLFamilial aggregation of Paget’s disease of boneJ Bone Miner Res1991654955002068956
   PubMed Web of Science ®Google Scholar
• LaurinNBrownJPLemainqueAPaget disease of bone: Mapping of two loci at 5q35-qter and 5q31Am J Hum Genet200169352854311473345
   PubMed Web of Science ®Google Scholar
• MichouLColletCLaplancheJLOrcelPCornelisFGenetics of Paget’s disease of boneJoint Bone Spine200673324324816574459
   PubMed Web of Science ®Google Scholar
• FotinoMHaymovitsAFalkCTEvidence for linkage between HLA and Paget’s diseaseTransplant Proc19779418671868146288
   PubMed Web of Science ®Google Scholar
• HughesAEShearmanAMWeberJLGenetic linkage of familial expansile osteolysis to chromosome 18qHum Mol Genet1994323593617911698
   PubMed Web of Science ®Google Scholar
• KovachMJWaggonerBLealSMClinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: Hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementiaMol Genet Metab200174445847511749051
   PubMed Web of Science ®Google Scholar
• SparksABPetersonSNBellCMutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget’s disease of bone and osteosarcomaCalcif Tissue Int200168315115511351498
   PubMed Web of Science ®Google Scholar
• WuytsWVan WesenbeeckLMorales-PigaAEvaluation of the role of RANK and OPG genes in Paget’s disease of boneBone200128110410711165949
   PubMed Web of Science ®Google Scholar
• AlbaghaOMViscontiMRAlonsoNGenome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of boneNat Genet201042652052420436471
   PubMed Web of Science ®Google Scholar
• HockingLJHerbertCANichollsRKGenomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35Am J Hum Genet20016951055106111555792
   PubMed Web of Science ®Google Scholar
• LaurinNBrownJPMorissetteJRaymondVRecurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of boneAm J Hum Genet20027061582152811992264
   PubMed Web of Science ®Google Scholar
• HockingLJLucasGJDaroszewskaADomain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s diseaseHum Mol Genet200211222735273912374763
   PubMed Web of Science ®Google Scholar
• LucasGJRichesPLHockingLJIdentification of a major locus for Paget’s disease on chromosome 10p13 in families of British descentJ Bone Miner Res2008231586317907922
   PubMed Web of Science ®Google Scholar
• GoodDABusfieldFFletcherBHLinkage of Paget disease of bone to a novel region on human chromosome 18q23Am J Hum Genet200270251752511742440
   PubMed Web of Science ®Google Scholar
• GoodDABusfieldFFletcherBHIdentification of SQSTM1 mutations in familial Paget’s disease in Australian pedigreesBone200435127728215207768
   PubMed Web of Science ®Google Scholar
• DaroszewskaAHockingLJMcGuiganFESusceptibility to Paget’s disease of bone is influenced by a common polymorphic variant of osteoprotegerinJ Bone Miner Res20041991506151115312251
   PubMed Web of Science ®Google Scholar
• BeyensGDaroszewskaAde FreitasFIdentification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget’s disease of boneJ Bone Miner Res20072271062107117388729
   PubMed Web of Science ®Google Scholar
• WattsGDWymerJKovachMJInclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing proteinNat Genet200436437738115034582
   PubMed Web of Science ®Google Scholar
• LucasGJMehtaSGHockingLJEvaluation of the role of valosin-containing protein in the pathogenesis of familial and sporadic Paget’s disease of boneBone200638228028516199218
   PubMed Web of Science ®Google Scholar
• ChungPYBeyensGBoonenSThe majority of the genetic risk for Paget’s disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genesHum Genet2010128661562620839008
   PubMed Web of Science ®Google Scholar
• MorissetteJLaurinNBrownJPSequestosome 1: Mutation frequencies, haplotypes, and phenotypes in familial Paget’s disease of boneJ Bone Miner Res.200621Suppl 2P38P4417229007
   PubMed Web of Science ®Google Scholar
• CundyTBollandMPaget disease of boneTrends Endocrinol Metab200819724625318691901
   PubMed Web of Science ®Google Scholar
• ColletCMichouLAudranMPaget’s disease of bone in the French population: Novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlationsJ Bone Miner Res200722231031717129171
   PubMed Web of Science ®Google Scholar
• MichouLMorissetteJGagnonERNovel SQSTM1 mutations in patients with Paget’s disease of bone in an unrelated multiethnic American populationBone201148345646021073987
   PubMed Web of Science ®Google Scholar
• BeyensGVan HulEVan DriesscheKEvaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget’s diseaseCalcif Tissue Int200475214415215164150
   PubMed Web of Science ®Google Scholar
• CaveyJRRalstonSHSheppardPWLoss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget’s disease of boneCalcif Tissue Int200678527127716691492
   PubMed Web of Science ®Google Scholar
• NajatDGarnerTHagenTCharacterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget’s disease of boneJ Bone Miner Res200924463264219049332
   PubMed Web of Science ®Google Scholar
• LayfieldRThe molecular pathogenesis of Paget disease of boneExpert Rev Mol Med200792711317903332
   PubMedGoogle Scholar
• DuranASerranoMLeitgesMThe atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesisDev Cell20046230330914960283
   PubMed Web of Science ®Google Scholar
• ChamouxECoutureJBissonMMorissetteJBrownJPRouxSThe p62 P392L mutation linked to Paget’s disease induces activation of human osteoclastsMol Endocrinol200923101668168019589897
   PubMedGoogle Scholar
• KerscherOFelberbaumRHochstrasserMModification of proteins by ubiquitin and ubiquitin-like proteinsAnnu Rev Cell Dev Biol20062215918016753028
   PubMed Web of Science ®Google Scholar
• ReinsteinECiechanoverANarrative review. Protein degradation and human diseases: The ubiquitin connectionAnn Intern Med2006145967668417088581
   PubMed Web of Science ®Google Scholar
• SumpterRJrLevineBSelective autophagy and virusesAutophagy201173 [Epub ahead of print].
   Web of Science ®Google Scholar
• ShellySLukinovaNBambinaSBermanACherrySAutophagy is an essential component of Drosophila immunity against vesicular stomatitis virusImmunity200930458859819362021
   PubMed Web of Science ®Google Scholar
• SeglenPOBohleyPAutophagy and other vacuolar protein degradation mechanismsExperientia19924821581721740188
   PubMedGoogle Scholar
• CuervoAMAutophagy: In sickness and in healthTrends Cell Biol2004142707715102438
   PubMed Web of Science ®Google Scholar
• HaradaMKumemuraHOmaryMBProteasome inhibition induces inclusion bodies associated with intermediate filaments and fragmentation of the Golgi apparatusExp Cell Res20032881606912878159
   PubMed Web of Science ®Google Scholar
• KomatsuMWaguriSChibaTLoss of autophagy in the central nervous system causes neurodegeneration in miceNature2006441709588088416625205
   PubMed Web of Science ®Google Scholar
• ZatloukalKFrenchSWStumptnerCFrom Mallory to Mallory-Denk bodies: What, how and why?Exp Cell Res2007313102033204917531973
   PubMed Web of Science ®Google Scholar
• RimaBKDuprexWPMolecular mechanisms of measles virus persistenceVirus Res2005111213214715893837
   PubMed Web of Science ®Google Scholar
• ReddySVMenaaCSingerFRMeasles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget’s disease of boneExp Hematol199927101528153210517494
   PubMed Web of Science ®Google Scholar
• MottetGCurranJRouxLIntracellular stability of nonreplicating paramyxovirus nucleocapsidsVirology19901761172158685
   PubMed Web of Science ®Google Scholar
• GriffinDEMeasles virus-induced suppression of immune responsesImmunol Rev201023617618920636817
   PubMed Web of Science ®Google Scholar
• EhrlichLARoodmanGDThe role of immune cells and inflammatory cytokines in Paget’s disease and multiple myelomaImmunol Rev200520825226616313353
   PubMed Web of Science ®Google Scholar
• MurabayashiNKurita-TaniguchiMAyataMMatsumotoMOguraHSeyaTSusceptibility of human dendritic cells (DCs) to measles virus (MV) depends on their activation stages in conjunction with the level of CDw150: Role of toll stimulators in DC maturation and MV amplificationMicrobes Infect20024878579412270725
   PubMed Web of Science ®Google Scholar
• JinZLiYPittiRCullin 3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signalingCell2009137472173519427028
   PubMed Web of Science ®Google Scholar
• GoodeALayfieldRRecent advances in understanding the molecular basis of Paget disease of boneJ Clin Pathol201063319920319858527
   PubMed Web of Science ®Google Scholar
• SelbyPLDaviesMMeeAPCanine distemper virus induces human osteoclastogenesis through NF-kappaB and sequestosome 1/P62 activationJ Bone Miner Res200621111750175617002577
   PubMed Web of Science ®Google Scholar
• BrandwoodCPHoylandJAHillarbyMCApoptotic gene expression in Paget’s disease: A possible role of Bcl-2J Pathol2003201350451214595764
   PubMed Web of Science ®Google Scholar
• KukitaAChenuCMcManusLMMundyGRRoodmanGDAtypical multinucleated cells form in long-term marrow cultures from patients with Paget’s diseaseJ Clin Invest1990854128012862318982
   PubMed Web of Science ®Google Scholar
• KuriharaNReddySVArakiNRole of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget’s diseaseJ Bone Miner Res20041971154116415176999
   PubMed Web of Science ®Google Scholar
• MenaaCReddySVKuriharaNEnhanced RANK ligand expression and responsivity of bone marrow cells in Paget’s disease of boneJ Clin Invest2000105121833183810862799
   PubMed Web of Science ®Google Scholar
• RoodmanGDKuriharaNOhsakiYInterleukin 6. A potential autocrine/paracrine factor in Paget’s disease of boneJ Clin Invest199289146521729280
   PubMed Web of Science ®Google Scholar
• KuriharaNReddySVMenaaCAndersonDRoodmanGDOsteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotypeJ Clin Invest2000105560761410712432
   PubMed Web of Science ®Google Scholar
• KuriharaNHirumaYYamanaKContributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget’s diseaseCell Metab2011131233421195346
   PubMed Web of Science ®Google Scholar
• KuriharaNZhouHReddySVExpression of measles virus nucleocapsid protein in osteoclasts induces Paget’s disease-like bone lesions in miceJ Bone Miner Res200621344645516491293
   PubMed Web of Science ®Google Scholar
• RalstonSHPathogenesis of Paget’s disease of boneBone200843581982518672105
   PubMed Web of Science ®Google Scholar
• KuriharaNHirumaYZhouHMutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget diseaseJ Clin Invest2007117113314217187080
   PubMed Web of Science ®Google Scholar
• HirumaYKuriharaNSublerMAA SQSTM1/p62 mutation linked to Paget’s disease increases the osteoclastogenic potential of the bone microenvironmentHum Mol Genet200817233708371918765443
   PubMed Web of Science ®Google Scholar
• RoodmanGDInsights into the pathogenesis of Paget’s diseaseAnn N Y Acad Sci2010119217618020392234
   PubMed Web of Science ®Google Scholar
• LylesKWSirisESSingerFRMeunierPJA clinical approach to diagnosis and management of Paget’s disease of boneJ Bone Miner Res20011681379138711499860
   PubMed Web of Science ®Google Scholar
• TakataSHashimotoJNakatsukaKGuidelines for diagnosis and management of Paget’s disease of bone in JapanJ Bone Miner Metab200624535936716937267
   PubMed Web of Science ®Google Scholar
• AdamiSBartolozziPBrandiML[Italian guidelines for the diagnosis and treatment of Paget’s disease of bone]Reumatismo2007592153168 Italian.17603696
   PubMedGoogle Scholar
• WermersRATiegsRDAtkinsonEJAchenbachSJMeltonLJ3rdMorbidity and mortality associated with Paget’s disease of bone: A population-based studyJ Bone Miner Res200823681982518269308
   PubMed Web of Science ®Google Scholar
• SingerFRPaget disease: When to treat and when not to treatNat Rev Rheumatol20095948348919652650
   PubMed Web of Science ®Google Scholar
• MeunierPJVignonETherapeutic strategy in Paget’s disease of boneBone199917Suppl 5489S491S8573424
   PubMed Web of Science ®Google Scholar
• BrownJPChinesAAMyersWREusebioRARitter-HrncirikCHayesCWImprovement of pagetic bone lesions with risedronate treatment: A radiologic studyBone200026326326710709999
   PubMed Web of Science ®Google Scholar
• BrownJPHoskingDJSte-MarieLRisedronate, a highly effective, short-term oral treatment for Paget’s disease: A dose-response studyCalcif Tissue Int199964293999914313
   PubMed Web of Science ®Google Scholar
• BrownJPMetabolic bone diseases: Treating Paget disease: when matters more than howNat Rev Rheumatol200951266366519946296
   PubMed Web of Science ®Google Scholar
• LangstonALCampbellMKFraserWDMacLennanGSSelbyPLRalstonSHRandomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget’s disease of boneJ Bone Miner Res2010251203119580457
   PubMed Web of Science ®Google Scholar
• ReidIRCundyTBollandMJGreyAResponse to publication of PRISM trialJ Bone Miner Res20102561463146420499373
   PubMed Web of Science ®Google Scholar
• WhitsonHELobaughBLylesKWSevere hypocalcemia following bisphosphonate treatment in a patient with Paget’s disease of boneBone200639495495816769264
   PubMed Web of Science ®Google Scholar
• ReidIRHoskingDJBisphosphonates in Paget’s diseaseBone992010 [Epub ahead of print]
   Google Scholar
• ChambersTJMagnusCJCalcitonin alters behaviour of isolated osteoclastsJ Pathol1982136127397057295
   PubMed Web of Science ®Google Scholar
• FleischHRussellRGFrancisMDDiphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivoScience1969165899126212645803538
   PubMed Web of Science ®Google Scholar
• RogersMJNew insights into the molecular mechanisms of action of bisphosphonatesCurr Pharm Des20039322643265814529538
   PubMedGoogle Scholar
• MillerPDBrownJPSirisESHoseyniMSAxelrodDWBekkerPJA randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget’s disease of bone. Paget’s Risedronate/Etidronate Study GroupAm J Med1999106551352010335722
   PubMed Web of Science ®Google Scholar
• GrayREYatesAJPrestonCJSmithRRussellRGKanisJADuration of effect of oral diphosphonate therapy in Paget’s disease of boneQ J Med1987642457557672966965
   PubMedGoogle Scholar
• FraserWDStampTCCreekRASawyerJPPicotCA double-blind, multicentre, placebo-controlled study of tiludronate in Paget’s disease of bonePostgrad Med J1997738624965029307742
   PubMed Web of Science ®Google Scholar
• AndersonDCRichardsonPCBrownJKIntravenous pamidronate: Evolution of an effective treatment strategySemin Arthritis Rheum19942342732758009254
   PubMed Web of Science ®Google Scholar
• SirisEWeinsteinRSAltmanRComparative study of alendronate versus etidronate for the treatment of Paget’s disease of boneJ Clin Endocrinol Metab19968139619678772558
   PubMed Web of Science ®Google Scholar
• ReidIRMillerPLylesKComparison of a single infusion of zoledronic acid with risedronate for Paget’s diseaseN Engl J Med2005353989890816135834
   PubMed Web of Science ®Google Scholar
• WalshJPWardLCStewartGOA randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget’s disease of boneBone200434474775415050907
   PubMed Web of Science ®Google Scholar
• MerlottiDGennariLMartiniGComparison of different intravenous bisphosphonate regimens for Paget’s disease of boneJ Bone Miner Res200722101510151717605632
   PubMed Web of Science ®Google Scholar
• HooperMFaustinoAReidIRRandomized, active-controlled study of once-weekly alendronate 280 mg high dose oral buffered solution for treatment of Paget’s diseaseOsteoporos Int200920114115018536953
   PubMed Web of Science ®Google Scholar
• HoskingDLylesKBrownJPLong-term control of bone turnover in Paget’s disease with zoledronic acid and risedronateJ Bone Miner Res200722114214817032148
   PubMed Web of Science ®Google Scholar
• ReidILylesKWSuGLong-term efficacy of zoledronic acid compared with risedronate in Paget’s diseaseBone201047Suppl 1OC21
   Google Scholar
• PapapoulosSEEekhoffMEZwindermanAHAcquired resistance to bisphosphonates in Paget’s disease of boneJ Bone Miner Res.200621Suppl 2P88P9117229015
   PubMed Web of Science ®Google Scholar
• PazianasMAbrahamsenBSafety of bisphosphonatesBone1122011 [Epub ahead of print]
   Google Scholar
• HoskingDJPrediction and assessment of the response of Paget’s disease to bisphosphonate treatmentBone199924Suppl 569S71S10321933
   PubMed Web of Science ®Google Scholar
• EbertRZeckSKrugRPulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiationBone200944585886419442618
   PubMed Web of Science ®Google Scholar
• GreenJClezardinPThe molecular basis of bisphosphonate activity: A preclinical perspectiveSemin Oncol.201037Suppl 1S3S1120682369
   PubMed Web of Science ®Google Scholar
• RomasEClinical applications of RANK-ligand inhibitionIntern Med J200939211011619356186
   PubMed Web of Science ®Google Scholar
• CrockettJCMellisDJScottDIHelfrichMHNew knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: Focus on the RANK/RANKL axisOsteoporos Int201122112020458572
   PubMed Web of Science ®Google Scholar
• RoodmanGDInterleukin-6: An osteotropic factor?J Bone Miner Res1992754754781615755
   PubMed Web of Science ®Google Scholar
• Corral-GudinoLdel Pino-MontesJGarcia-AparicioJAlonso-GarridoMGonzalez-SarmientoRPaget’s disease of bone is not associated with common polymorphisms in interleukin-6, interleukin-8 and tumor necrosis factor alpha genesCytokine201052314615020709566
   PubMed Web of Science ®Google Scholar
• NishimotoNMiyasakaNYamamotoKKawaiSTakeuchiTAzumaJLong-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): Evidence of safety and efficacy in a 5-year extension studyAnn Rheum Dis200968101580158419019888
   PubMed Web of Science ®Google Scholar
• DayerJMChoyETherapeutic targets in rheumatoid arthritis: The interleukin-6 receptorRheumatology (Oxford)2010491152419854855
   PubMed Web of Science ®Google Scholar
• MarshallMJEvansSFSharpCAPowellDEMcCarthyHSDavieMWIncreased circulating Dickkopf-1 in Paget’s disease of boneClin Biochem20094210–1196596919389391
   PubMed Web of Science ®Google Scholar
• McCarthyHSMarshallMJDickkopf-1 as a potential therapeutic target in Paget’s disease of boneExpert Opin Ther Targets201014222123020055719
   PubMed Web of Science ®Google Scholar
• RoodmanGDStudies in Paget’s disease and their relevance to oncologySemin Oncol.2001284Suppl 11152111544571
   PubMed Web of Science ®Google Scholar
• RoodmanGDOsteoblast function in myelomaBone201148113514020601285
   PubMed Web of Science ®Google Scholar
• ZhouFLMengSZhangWGPeptide-based immunotherapy for multiple myeloma: Current approachesVaccine201028375939594620619381
   PubMed Web of Science ®Google Scholar
• LiggettACrawfordLJWalkerBMorrisTCIrvineAEMethods for measuring proteasome activity: Current limitations and future developmentsLeuk Res201034111403140920674016
   PubMed Web of Science ®Google Scholar
• Chanan-KhanAABorrelloILeeKPReeceDEDevelopment of target-specific treatments in multiple myelomaBr J Haematol2010151131520618339
   PubMed Web of Science ®Google Scholar
• RoodmanGDNovel targets for myeloma bone diseaseExpert Opin Ther Targets200812111377138718851694
   PubMed Web of Science ®Google Scholar
• DealCFuture therapeutic targets in osteoporosisCurr Opin Rheumatol200921438038519461517
   PubMed Web of Science ®Google Scholar
• MichouLChamouxECoutureJMorissetteJBrownJPRouxSGene expression profile in osteoclasts from patients with Paget’s disease of boneBone201046359860319925894
   PubMed Web of Science ®Google Scholar
• NagyZBGergelyPDonathJBorgulyaGCsanadMPoorGGene expression profiling in Paget’s disease of bone: Upregulation of interferon signaling pathways in pagetic monocytes and lymphocytesJ Bone Miner Res200823225325918197754
   PubMed Web of Science ®Google Scholar
• BruzzanitiABaronRMolecular regulation of osteoclast activityRev Endocr Metab Disord200671–212313916951988
   PubMed Web of Science ®Google Scholar
• NealeSDSchulzeESmithRAthanasouNAThe influence of serum cytokines and growth factors on osteoclast formation in Paget’s diseaseQ J Med2002954233240
   Google Scholar
• AharinejadSPaulusPSioudMColony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in miceCancer Res200464155378538415289345
   PubMed Web of Science ®Google Scholar
• ChengHClarksonPWGaoDPachecoMWangYNielsenTOTherapeutic antibodies targeting CSF1 impede macrophage recruitment in a xenograft model of tenosynovial giant cell tumorSarcoma2010201017452820981142
   PubMedGoogle Scholar
• VaananenKMechanism of osteoclast mediated bone resorption – rationale for the design of new therapeuticsAdv Drug Deliv Rev200557795997115876398
   PubMed Web of Science ®Google Scholar